Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Life Insurance

Insurance Execs Weigh Ethical Challenges Facing Industry

X
Your article was successfully shared with the contacts you provided.

Recommending a life settlement to a financially strapped senior may be tempting to the agent who stands to make a hefty commission on the transaction. But the ethical thing to do is to first discuss the alternatives, including a sale of the client’s life insurance policy to his or her kids.

This was one of a number of suggestions offered during a panel discussion held at the American College’s Bryn Mawr, Pa.-based campus last month. The panelists, including executives from New York Life, Northwestern Mutual, Clark Consulting and Protective Life, offered perspectives on ethical issues bearing on compensation disclosure, the sale and marketing of annuities and life settlements.

The last of these drew the most critical comments. John O’Byrne, a chief conduct officer at New York Life, New York, observed that life settlements engender a “conflict of interest” in that the settlement company benefits financially by the insured’s early death. Because of this conflict, O’Bryne said New York Life does not permit its agents to sell the solution.

Panelists cited other reasons for avoiding life settlements. Among them: the high commissions that agents can earn on the transaction; possibly adverse tax consequences for the insured; and the potentially negative impact for insurers and consumers over the long term.

Panelists noted that because settlement companies purchase life insurance policies for investment (rather than protection) purposes, the tax advantages long enjoyed by policyholders–tax-deferred growth of a policy’s cash value and income tax-free distribution of death benefits–are at risk. Congress and state legislatures may decide that such advantages are no longer in the public interest, they said.

Ultimately, said John Johns, CEO of Protective Life, Birmingham, Ala., the growth of life settlements (a market valued by Conning Research and Consulting at $19 billion, up from $2 billion in 2002) could lead to higher premiums for clients. That’s because insurers will have to factor into their premium rate calculations a lower percentage of policy lapses than that which the industry has traditionally enjoyed.

“Premium rates have assumed a historic pattern of policy lapses that have proved no longer to be true,” said Johns. “The insurer suffers as a result. Longer-term, if [life settlements] become widespread, then companies will have to assume that their products will be sold into the secondary market, which will raise the cost of insurance to all consumers.”

All of the panelists said the hypothetical client described in one of three case studies, a 70-year-old man facing financial difficulties who desires to cash out his life policy, should consider alternatives to a life settlements. Solutions offered, short of a policy surrender, included borrowing against the policy’s cash value; transacting a 1035 exchange; selling the policy to children, who could then place the policy in trust for the benefit of their children; and securing a bank loan, pledging the policy’s death benefit or a percentage thereof as collateral.

While espousing full disclosure by agents about alternatives to life settlements, panelists qualified their support of compensation disclosure. Echoing the comments of the panelists, Edward Zore, CEO of Northwestern Mutual, Milwaukee, said agents should tell clients how they’re compensated generally, but should not have to convey a dollar amount. He added that such detailed disclosure, and the idea that clients would be well served if agents received levelized (rather than front-loaded or “heaped” commissions) would be counterproductive.

“Disclosing exactly how much one gets paid would [be detrimental] to the sale process,” said Zore. “Also, levelized commissions are nice in theory, but they’ll only result in fewer agents selling fewer policies.”

Panelists rejected a suggestion of the moderator, Jim Mitchell, a former CEO of IDS Life, Minneapolis, Minn., that agents disclose premium costs in greater detail. Zore said that making apples-to-apples comparisons of commissions and products from one company to the next is problematic, in part because of variations in underwriting classifications and product features. Johns agreed, adding that differences in insurers’ distribution channels can also skew client perceptions of policy costs.

“It may appear to the client that our commissions are higher than Northwestern Mutual’s, even though the total cost of our respective field forces are probably comparable,” said Johns. “So there’s an issue as to whether disclosure of commissions would be fair, meaningful and representative of our true costs.”

He added that when dealing with clients angered by front-loaded commissions they view as unreasonably high, agents should point out that they’re entitled to a free-look period during which they can request a refund of the premium paid; review with clients why they purchased the policy; and, as necessary, disclose market data indicating whether clients received a fair price for the purchase.

As with compensation disclosure, panelists said product complexity and differences have to be weighed when deciding whether an agent inappropriately recommended replacing an existing annuity with a new one. O’Byrne said that if the agent’s compliance record indicated the recommendation was a one-time event, then additional education or supervision of the agent may be necessary. But if determined to be a “serial churner,” then suspension or termination of the agent’s contract, among other penalties, should be considered, he said.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.